Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

This study has been completed.

Study NCT00499811 Information provided by National Cancer Institute (NCI)

First Received: July 10, 2007 Last Updated: August 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)

Publications:

Egorin MJ, Kummar S, Sarantopoulos J, et al.: Phase I study of vorinostat for patients with advanced solid tumors and hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI #8057). [Abstract] J Clin Oncol 28 (Suppl 15): A-2545, 2010.

Ramalingam SS, Kummar S, Sarantopoulos J, Shibata S, LoRusso P, Yerk M, Holleran J, Lin Y, Beumer JH, Harvey RD, Ivy SP, Belani CP, Egorin MJ. Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. J Clin Oncol. 2010 Oct 10;28(29):4507-12. Epub 2010 Sep 13.